#USA #Washington, D.C. #Ascent #LIFT #DIA

DIA ASCENT: Paving the Way for Biotech Innovation

The Drug Information Association (DIA) has recently announced the launch of a groundbreaking platform known as DIA ASCENT. This new global initiative is specifically designed to encourage and support innovation in the early development stages of biotechnology products. Alongside this platform, DIA has introduced an exciting program called LIFT (Linking Innovation, Funding, and Translation) to help connect emerging biotech startups with vital resources.

Addressing Challenges in Biotech Innovation

In the fast-evolving field of biotechnology, startups often face numerous challenges during their formative phases. These obstacles typically include limited access to funding, fragmented expertise, unclear regulatory pathways, and significant execution gaps. By addressing these issues comprehensively, DIA ASCENT aims to expand its role as a trustworthy, multi-sector convener, facilitating early-stage innovation in biotech.

DIA ASCENT seeks to strengthen the global life sciences innovation portfolio through specialized education, mentorship opportunities, regulatory insights, and international visibility. By leveraging its vast network and resources, the platform aims to equip biotech companies with the tools they need to thrive.

The LIFT Series: A Structured Approach

The LIFT Series will unfold in three integrated phases throughout 2026, each designed to offer tailored guidance and support for biotech and startup companies at various stages of their development journey:

Phase I: Launch of Virtual Masterclass Series

Starting in February 2026, the initiative kicks off with a Virtual Masterclass Series. This educational offering will include expert-led sessions that focus on critical topics such as fundraising, drug development (including the role of artificial intelligence), regulatory strategy, clinical development, and financial modeling.

Phase II: Engaging at DIA Europe 2026

The second phase will feature the LIFT program as part of the DIA Europe 2026 event in Rotterdam, Netherlands, scheduled for March 24-26, 2026. Here, attendees can benefit from a dedicated LIFT agenda catering to biotechnology and startups. This event will bring together over 2,500 professionals, providing a platform for expert coaching, live pitch competitions, roundtable discussions with regulators and investors, and select networking opportunities.

Phase III: Highlights at the DIA 2026 Global Annual Meeting

The culmination of the LIFT Series will take place during the DIA 2026 Global Annual Meeting, happening from June 14-18, 2026, in Philadelphia, Pennsylvania. This event will feature an expanded LIFT program, showcasing Startup Row and two specialized pitch events focused on drug development, therapies, and biotechnology innovation within a global forum for over 4,000 participants.

Commitment to the Life Sciences Community

"Our mission has always been to bring together the global life sciences community to enhance health worldwide," stated Marwan Fathallah, CEO of DIA. "With ASCENT and the LIFT Series, we extend our initiative to the initial stages of innovation, empowering startups with the perspective, connections, and visibility required to advance promising science and strengthen the entire ecosystem."

Registration and Future Opportunities

Registration is now open for the LIFT Virtual Masterclass Series, with details for Annual Meeting registrations and pitch competitions available soon. The call for submissions will be announced shortly, ensuring opportunities for biotech companies to get involved.

For more information about the ASCENT platform and the LIFT program, visit DIA's website.

About DIA

Founded in 1964 and headquartered in Washington, D.C., the Drug Information Association (DIA) is a leading global nonprofit dedicated to advancing the life sciences. The organization supports collaboration in drug development, medical devices, and diagnostics to create a healthier world. DIA offers comprehensive networking opportunities, educational resources, research publications, and professional development programs to members across over 80 countries.

Discover more at DIAglobal.org.